柚皮苷对破骨细胞凋亡的影响
DOI:
作者:
作者单位:

天津市天津医院

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金资助项目(81871777;31600769)


Effect of naringin on apoptosis of osteoclasts
Author:
Affiliation:

Tianjin Hospital

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    [目的] 探讨不同浓度柚皮苷单体对破骨细胞的凋亡的影响及相关机制。[方法] 采用100ng/ml浓度RANKL诱导小鼠单核细胞RAW264.7细胞株获取破骨细胞,之后采用含有柚皮苷培养基对破骨细胞进行干预3天,采用TRAP染色观察破骨细胞数量的变化,扫描电镜观察不同组别破骨细胞在骨薄片上的骨吸收功能,流式细胞术检测破骨细胞凋亡的变化,采用荧光定量 PCR观测破骨细胞凋亡基因BCL-2、BAX、 Caspase-3及MMP-9表达的影响。[结果] 与对照组比较,各组浓度柚皮苷均可以有效的减少RANKL诱导破骨细胞的数量(P<0.05),其中200μg/ml浓度柚皮苷组破骨细胞数量最少(P<0.01);同样各柚皮苷组的破骨细胞骨吸收面积减少(P<0.05),其中200μg/ml浓度柚皮苷抑制破骨细胞骨吸收能力最强(P<0.01);流式细胞术检测显示各浓度柚皮苷组可增加破骨细胞的凋亡率(P<0.05),其中20μg/ml和200μg/ml浓度柚皮苷组强于2μg/ml柚皮苷组;与0μg/ml浓度柚皮苷组比较,各柚皮苷组mRNA BCL-2和MMP-9相对表达量降低(P<0.05);其中200μg/ml柚皮苷组最为显著(P<0.01);柚皮苷组mRNA BAX和 Caspase-3相对表达量升高(P<0.05),其中200μg/ml柚皮苷组 Caspase-3相对表达量升高最为显著(P<0.01)。[结论] 柚皮苷可降低破骨细胞数量和骨吸收能力,下调破骨细胞凋亡相关的BCL-2和上调BAX、 caspase-3 mRNA表达,增加破骨细胞凋亡。

    Abstract:

    [Objective] To investigate the effects of naringin on osteoclast apoptosis and related mechanisms.[Methods] RAW264.7 cell line was used to induce osteoclasts at a concentration of 100 ng/ml RANKL for 5 days. Different concentrations of naringin were used to intervene osteoclasts for 3 days. TRAP staining was used to observe the number of naringin on osteoclasts. The effects of different concentrations of naringin on bone resorption of osteoclasts were observed by scanning electron microscopy. Flow cytometry was used to detect the effect of different concentrations of naringin on osteoclast apoptosis. The effect of naringin on the expression of apoptosis-related genes BCL-2, BAX, Caspase-3 and MMP-9 by real-time fluorescence quantitative PCR. [Results]Compared with the control group, the concentration of naringin in each group effectively reduce the number of RANKL-induced osteoclasts (P<0.05), and the concentration of 200μg/ml naringin is the strongest ( P<0.01). The bone resorption area of osteoclasts in each naringin group was decreased (P<0.05), and the concentration of naringin at 200μg/ml had the strongest inhibition on bone resorption of osteoclasts (P<0.01). Cytometry showed that the concentration of naringin could increase the apoptosis rate of osteoclasts (P<0.05), and the concentration of 20μg/ml and 200μg/ml naringin was stronger than that of 2μg/ml naringin group. Compared with the naringin group at 0μg/ml, the relative expression levels of BCL-2 and MMP-9 in the naringin group were decreased (P<0.05); 200μg/ml naringin group was the most significant (P<0.01); The relative expression levels of BAX and Caspase-3 in dermatan group were increased (P<0.05), and the relative expression of Caspase-3 at 200μg/ml naringin group to be the optimal dosage with satisfying therapeutic effects. (P<0.01). [Conclusion] Naringin down-regulate BCL-2 and up-regulate BAX and caspase-3 mRNA expression, and promote osteoclast apoptosis, thereby reducing the number and activity of osteoclasts. Among them, the concentration of 200 μg/ml was the strongest.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-10-21
  • 最后修改日期:2020-08-31
  • 录用日期:2020-09-24
  • 在线发布日期:
  • 出版日期: